MRS-4203

N/A

Report date: 2025/01/26 16:26:25
NME

Base Information

Drug NameMRS-4203
Drug Alias Nameadenosine kinase inhibitor (Rutgers University/National Institutes of Health)MRS-4203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine kinase inhibitors
TargetsAdenosine kinase
Therapy Area/IndicationsEpilepsyNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRutgers University
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthRutgers University
Inactive CompaniesN/A
Active IndicationsEpilepsyNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A